Mandelker et al. reported a cohort with 35 wild-type GIST patients, in which they found germline pathogenic variants (in the genes SDHA, SDHB, SDHC, NF1, and KIT) in 70% (24/35) [51]. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.